Anthera Pharmaceuticals, Inc.
ANTH
ANTH was delisted on the 27th of June, 2018.
38 hedge funds and large institutions have $35.3M invested in Anthera Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
28% more call options, than puts
Call options by funds: $147K | Put options by funds: $115K
9% more funds holding
Funds holding: 35 → 38 (+3)
5% more capital invested
Capital invested by funds: $33.5M → $35.3M (+$1.78M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$562K |
| 2 |
Franklin Resources
San Mateo,
California
|
+$472K |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$403K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$178K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$132K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$741K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$27.1K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$13.9K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.5K |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.73K |
ANTH Hedge Fund Activity: Q2 2014 in Review
38 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Anthera Pharmaceuticals, Inc. (ANTH) for Q2 2014, worth a combined $35.3M — up 5.3% from $33.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ANTH positions and 1 closed out — a net gain of 3 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was Rhenman & Partners Asset Management, adding an estimated $562K. The largest seller was Sabby Management, cutting an estimated $741K.
- 38 institutional investors held Anthera Pharmaceuticals, Inc. (ANTH) as of Q2 2014, up from 35 in Q1 2014.
- Funds reported $35.3M of Anthera Pharmaceuticals, Inc. stock for Q2 2014, up 5.3% quarter-over-quarter.
- 4 funds opened new Anthera Pharmaceuticals, Inc. positions in Q2 2014 and 1 closed out, a net change of +3 holders.
- The largest Anthera Pharmaceuticals, Inc. buyer in Q2 2014 was Rhenman & Partners Asset Management, an estimated $562K added.
- The largest Anthera Pharmaceuticals, Inc. seller in Q2 2014 was Sabby Management, an estimated $741K sold.
Based on aggregated 13F filings for Q2 2014.